5,8,11,14-eicosatetraynoic acid has been researched along with thiourea in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kagey-Sobotka, A; Lichtenstein, LM; MacGlashan, DW; Peters, SP; Warner, JA | 1 |
Center, DM; Makarski, JS; O'Brien, RF; Rounds, S; Seton, MP | 1 |
al-Mehdi, AB; Ayene, IS; Fisher, AB | 1 |
3 other study(ies) available for 5,8,11,14-eicosatetraynoic acid and thiourea
Article | Year |
---|---|
The pharmacologic modulation of mediator release from human basophils.
Topics: 1-Methyl-3-isobutylxanthine; 5,8,11,14-Eicosatetraynoic Acid; Alprostadil; Basophils; Cyclic AMP; Dimaprit; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Histamine Release; Humans; Isoproterenol; SRS-A; Thiourea | 1988 |
Thiourea causes endothelial cells in tissue culture to produce neutrophil chemoattractant activity.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Aorta, Thoracic; Arachidonic Acids; Cattle; Cells, Cultured; Chemotactic Factors; Culture Techniques; Endothelium; Humans; Interleukin-8; Lung; Meclofenamic Acid; Pulmonary Artery; Thiourea | 1984 |
Inhibition of lung tissue oxidation during ischemia/reperfusion by 2-mercaptopropionylglycine.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Deferoxamine; Ischemia; Lipid Peroxidation; Lung; Male; Oxidation-Reduction; Proteins; Rats; Rats, Sprague-Dawley; Reperfusion; Thiourea; Tiopronin | 1993 |